Why surgery won the SYNTAX trial and why it matters

Slides:

Advertisements

Similar presentations

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.

Advertisements

The “occasional open heart surgeon” revisited

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

Technological innovation in cardiothoracic surgery: A pragmatist's approach Pedro J. del Nido, MD The Journal of Thoracic and Cardiovascular Surgery

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Chetan Pasrija, MD, Michael A. Mazzeffi, MD, MPH, Zachary N. Kon, MD

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over two decades Jeanne Shen, BS, Shelly Lall,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention.

Pseudoaneurysm complicating right ventricle–to–pulmonary artery conduit surgery: Why single-center observational studies still matter Petros V. Anagnostopoulos,

Right internal thoracic artery or saphenous vein grafting

Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice? Yang Liu,

Juan A. Crestanello, MD, Richard C. Daly, MD

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials Hisato Takagi, MD, PhD,

Defining operative mortality: Impact on outcome reporting

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Michael E. Halkos, MD, MSc, Henry A

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

The lord of the rings Antonio Miceli, MD, PhD

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

Conduit conundrum: If not two, why three?

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Michael Mack, MD, David Taggart, MD

Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years

It's not “just a shunt” but sometimes it should be…

For everything there is a season

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

To bypass or stent? The changing rules of an advancing game

Bioengineered vascular grafts: So close and yet so far

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Fueling the heart: Shifting the myocardial metabolome by targeting endothelial autophagy Nicholas D. Andersen, MD The Journal of Thoracic and Cardiovascular.

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

A fate worse than death Jennifer S. Lawton, MD

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

The thoracoabdominal saga and heroes

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

The harder one looks, the more one finds

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Apples remain apples NO matter what

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Edward Y. Chan, MD, Michael J. Reardon, MD

Commentary: Radial artery and bilateral mammary arteries in coronary artery bypass grafting: How much is too much? Derrick Y. Tam, MD, Stephen E. Fremes,

Presentation transcript:

Why surgery won the SYNTAX trial and why it matters Michael Mack, MD, Heike Baumgarten, MD, Bruce Lytle, MD The Journal of Thoracic and Cardiovascular Surgery Volume 152, Issue 5, Pages 1237-1240 (November 2016) DOI: 10.1016/j.jtcvs.2016.04.083 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Causes of deaths in the SYNTAX randomized cohort: Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) comparison. MI, Myocardial infarction; CHF, congestive heart failure. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 1237-1240DOI: (10.1016/j.jtcvs.2016.04.083) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Causes of deaths in the SYNTAX randomized cohort: PCI and CABG comparison. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 1237-1240DOI: (10.1016/j.jtcvs.2016.04.083) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions